Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CODAC Behavioral Healthcare to Expand Addiction Treatment for Prisoners to Massachusetts

Hampden County Sheriff's Department Contracts with CODAC to Initiate Medication-Assisted Treatment for Inmates, Part of Statewide Pilot Program; CODAC's Nationally Recognized Work in Rhode Island Sets Model for Care


News provided by

CODAC Behavioral Healthcare

Sep 10, 2019, 08:00 ET

Share this article

Share toX

Share this article

Share toX


CRANSTON, R.I., Sept. 10, 2019 /PRNewswire-PRWeb/ -- CODAC Behavioral Healthcare, the largest non-profit, outpatient provider for opioid treatment in Rhode Island, today announced the expansion of its services to treat addiction during incarceration to Hampden County, MA. CODAC, which worked with the Rhode Island Department of Corrections (RIDOC) in launching the nation's first program to screen all inmates for opioid use disorder (OUD) and provide medication-assisted treatment (MAT) for those in need, has been selected by the Hampden County Sheriff's Department to implement a similar program in Hampden County, MA at each of its correctional facilities. The program began on September 1.

Nearly two-thirds of incarcerated people suffer from substance use disorders and, compared to the rest of the adult population, the opioid-related overdose death rate is 120 times higher for persons released from prisons and jails. The consensus best-practice approach for opioid-addiction treatment is MAT, and recent legislation in Massachusetts and other states has called for an increase in access to addiction medications for prisoners with a demonstrated need to help ease withdrawal symptoms and lower the risk of relapse when released.    

...We are excited to be working with the Hampden County Sheriff’s Department on this important step in advancing the message that addiction is a disease just like diabetes or cancer and evidence-based therapeutic approaches such as MAT should be available to all patients.

Post this

CODAC's nationally praised MAT program with RIDOC was associated with a 61 percent decrease in post-incarceration deaths and contributed to an overall drop in overdose deaths statewide in RI, as reported by a Brown University study and published in JAMA Psychiatry. CODAC is now also licensed as an Opioid Treatment Program (OTP) provider in Massachusetts.

"In the midst of our nation's opioid epidemic, we are excited to be working with the Hampden County Sheriff's Department on this important step in advancing the message that addiction is a disease just like diabetes or cancer and evidence-based therapeutic approaches such as MAT should be available to all patients," said Linda Hurley, President/CEO of CODAC. "What we have accomplished in RIDOC has proven beneficial to the entire state. It's scalable and feasible elsewhere, and we are always willing to help other states implement similar programs."

In Hampden County, opioid overdose deaths increased 84 percent from 2017 to 2018, even as the rate of deaths declined in much of the rest of the state. The Hampden County Sheriff's Department MAT initiative is part of a statewide pilot program established in 2018 by the Massachusetts Sheriffs' Association to provide MAT at five county correctional facilities in the Commonwealth: Middlesex, Franklin, Norfolk, Hampden and Hampshire. (Essex and Suffolk counties later asked to join the program.)

"Medication Assisted Treatment, along with the appropriate group and one on one counseling, is one more tool in our addiction recovery tool box we are now providing inmates," said Hampden Sheriff Nicholas Cocchi. "There has been a great sense of relief among the people who come to us knowing they will be able to continue their treatment thanks to our staff and the medical professionals working with us on behalf of CODAC Behavioral Healthcare. Medication Assisted Treatment just makes sense and providing it is the right thing to do."

The MAT program to be administered by CODAC to inmates at Hampden County correctional facilities will mirror the RIDOC program in offering counseling and behavioral therapies along with access to all three FDA-approved addiction medications: methadone, buprenorphine and naltrexone. Clinical criteria and inmate preference will be used to tailor the best treatment to each patient's individual needs. CODAC will operate a dispensary inside the Hampden County House of Correction to provide real-time MAT services, seven days per week.

The program will allow for continuation of MAT, new inductions and pre-release access. For those inmates who enter with an active MAT prescription, once a medication is confirmed, they will be allowed to continue their treatment regimen while incarcerated. Those inmates committed who report opioid use, past or present, will be assessed for eligibility and started on MAT, as appropriate. In addition, inmates who are currently sentenced, and not on medication, may be eligible to be started on MAT prior to release (this population typically includes inmates who were committed prior to the program starting, were not offered treatment/were withdrawn from their MAT treatment, and request to be stabilized on a medication prior to release).

Upon release, former inmates will return to their communities with a coordinated post-release plan to ensure continuity of care and assist in re-entry. Further, data collected from the Hampden County Sheriff's Department's MAT Initiative will be given to public agencies to help establish best practices that can be used in the state for serving this vulnerable population.

About CODAC Behavioral Healthcare
CODAC Behavioral Healthcare, a non-profit organization founded in 1971, is Rhode Island's oldest and largest provider of outpatient services for opioid use disorder, other substance use disorders, and concurrent behavioral health challenges. With eight locations across Rhode Island, CODAC has attained Center of Excellence designations for each of its treatment sites. CODAC has done extensive work with individuals involved in the criminal justice system since 1994 and, in 2016, launched a program with the Rhode Island Department of Corrections (RIDOC) that was the first of its kind in the United States to screen all inmates for opioid use disorder and provide medication-assisted treatment (MAT) for those in need. Results from CODAC's RIDOC program have been studied and published, and the program has been recognized as "a model for all 50 states" by the Department of Justice, SAMHSA and multiple other national agencies. In addition, CODAC is now licensed in Massachusetts to operate an Opioid Treatment Program (OTP). For more information about CODAC, visit: http://www.codacinc.org

Contact:
Alisha Bourdeau,CFO; CODAC
(401) 275-5038
abourdeau(at)codacinc.org

Bill Gordon; PR/Media Relations
646-924-6146
billgordon37(at)hotmail.com

SOURCE CODAC Behavioral Healthcare

Modal title

Photo: Linda Hurley, President/CEO of CODAC Behavioral Healthcare
Photo: Linda Hurley, President/CEO of CODAC Behavioral Healthcare
Photo: Linda Hurley, President/CEO of CODAC Behavioral Healthcare

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.